Abstract Objective Metacognitive therapy (MCT) and cognitive–behavior therapy (CBT) are effective treatments for generalized anxiety disorder. In this study, we followed‐up patients who had previously participated in a randomized controlled trial of MCT compared against CBT. Method We collected 9‐year follow‐up data on 39 out of 60 original patients (i.e., 65% response rate). Results At 9 years, the recovery rates were 57% for MCT and 38% for CBT (completer analysis). Following MCT, 43% maintained their recovery status and a further 14% achieved recovery. Following CBT, the sustained recovery rate was 13%, while a further 25% achieved recovery. Patients in the MCT condition showed significantly more improvement with respect to symptoms of w...
Background: Metacognitive therapy (MCT) is a relatively new approach to treating mental disorders. T...
Generalized Anxiety Disorder (GAD) in older adults has received little attention from researchers, d...
Metacognitive therapy (MCT) has shown promising outcomes across disorders, but, currently, little is...
Objective Metacognitive therapy (MCT) and cognitive–behavior therapy (CBT) are effective treatments...
Background Cognitive–behavioural therapy (CBT) is the treatment of choice for generalised anxiety di...
Recent years have seen a near-doubling of the number of studies examining the effects of psychothera...
Context: Generalized anxiety disorder (GAD) is a challenging clinical condition to manage. Recent ps...
We report a meta- and primary data-analysis investigating the efficacy of cognitive therapy (CT) for...
Forty two participants with generalized anxiety disorder were treated with either Metacognitive ther...
The efficacy of cognitive–behavioral therapy (CBT) for anxiety in adults is well established. In the...
The data were retrieved from a study comparing metacognitive therapy (MCT) to cognitive behavioral t...
Objective: Cognitive-behavior therapy (CBT) is considered the “golden standard” psychotherapy for ge...
This randomized controlled trial compared the effectiveness of metacognitive therapy (MCT) and intol...
Background. Generalized anxiety disorder is a common condition of excessive worry and tension which ...
Background: Individual metacognitive therapy (MCT) for generalized anxiety disorder (GAD) is well es...
Background: Metacognitive therapy (MCT) is a relatively new approach to treating mental disorders. T...
Generalized Anxiety Disorder (GAD) in older adults has received little attention from researchers, d...
Metacognitive therapy (MCT) has shown promising outcomes across disorders, but, currently, little is...
Objective Metacognitive therapy (MCT) and cognitive–behavior therapy (CBT) are effective treatments...
Background Cognitive–behavioural therapy (CBT) is the treatment of choice for generalised anxiety di...
Recent years have seen a near-doubling of the number of studies examining the effects of psychothera...
Context: Generalized anxiety disorder (GAD) is a challenging clinical condition to manage. Recent ps...
We report a meta- and primary data-analysis investigating the efficacy of cognitive therapy (CT) for...
Forty two participants with generalized anxiety disorder were treated with either Metacognitive ther...
The efficacy of cognitive–behavioral therapy (CBT) for anxiety in adults is well established. In the...
The data were retrieved from a study comparing metacognitive therapy (MCT) to cognitive behavioral t...
Objective: Cognitive-behavior therapy (CBT) is considered the “golden standard” psychotherapy for ge...
This randomized controlled trial compared the effectiveness of metacognitive therapy (MCT) and intol...
Background. Generalized anxiety disorder is a common condition of excessive worry and tension which ...
Background: Individual metacognitive therapy (MCT) for generalized anxiety disorder (GAD) is well es...
Background: Metacognitive therapy (MCT) is a relatively new approach to treating mental disorders. T...
Generalized Anxiety Disorder (GAD) in older adults has received little attention from researchers, d...
Metacognitive therapy (MCT) has shown promising outcomes across disorders, but, currently, little is...